|
Market Closed -
Nasdaq Stockholm
17:00:00 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 6.200 SEK | -2.36% |
|
-8.42% | +10.71% |
| 10-01 | Mendus presents five-year data for vididencel - first CML results expected in the fourth quarter | FW |
| 09-16 | Mendus Launches Early-stage Trial for Acute Myeloid Leukemia Treatment Combo | MT |
| Market Cap | 411M 40.97M 36.4M 33.97M 30.97M 58.4M 3.94B 58.95M 159M 2.01B 154M 150M 6.46B | P/E 2026 * |
-4.07x | P/E 2027 * | -6.19x |
|---|---|---|---|---|---|
| Enterprise Value | 432M 43.09M 38.29M 35.74M 32.57M 61.43M 4.14B 62M 168M 2.12B 162M 158M 6.8B | EV / Sales 2026 * |
56.7x | EV / Sales 2027 * | 1.39x |
| Free-Float |
34.74% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IMMU | Delayed | |
Deutsche Boerse AG
| 1YG0 | Delayed | |
|
CBOE
| Real-time | ||
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| 1YG0 | Delayed | |
|
CBOE
| IMMUs | Real-time | |
|
Boerse Muenchen
| 1YG0 | Real-time |
Last Transcript: Mendus AB
| 1 day | -2.36% | ||
| 1 week | -8.42% | ||
| Current month | -2.21% | ||
| 1 month | -13.17% | ||
| 3 months | +8.77% | ||
| 6 months | +37.93% | ||
| Current year | +10.71% |
| 1 week | 6.15 |  | 6.58 |
| 1 month | 6 | | 7.9 |
| Current year | 3.86 | | 8.49 |
| 1 year | 3.86 | | 8.49 |
| 3 years | 3.86 | | 16.38 |
| 5 years | 3.86 | | 126.8 |
| 10 years | 3.86 | | 640 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Manting
CEO | Chief Executive Officer | 54 | 15/03/2021 |
| Chief Executive Officer | 76 | 12/12/2019 | |
Lotta Ferm
DFI | Director of Finance/CFO | 60 | 27/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Christine Lind
CHM | Chairman | 52 | 21/01/2021 |
Helén Tuvesson
BRD | Director/Board Member | 64 | 31/12/2019 |
| Director/Board Member | 74 | 31/12/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/02/22 | Buy | Chief Technology Officer | 10,000 | 0.0050% | ||
| 24/02/22 | Buy | Chief Financial Officer | 10,000 | 0.0050% | ||
| 24/02/22 | Buy | Chief Financial Officer | 10,000 | 0.0050% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.36% | -8.42% | -10.14% | -25.21% | 41.91M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -3.11% | -2.32% | +23.28% | +77.03% | 59.26B | |
| +0.89% | -0.77% | +5.80% | +32.89% | 47.14B | |
| -0.96% | -6.11% | +26.70% | +31.24% | 42.91B | |
| +0.36% | +3.39% | +350.59% | +646.53% | 44.13B | |
| -0.20% | -0.53% | +6.84% | +99.07% | 40.79B | |
| -0.54% | +2.93% | +9.50% | +50.41% | 30.77B | |
| -2.68% | +5.11% | +33.11% | +19.50% | 29.31B | |
| +2.33% | -8.58% | -24.55% | +340.08% | 23.71B | |
| Average | -0.21% | -1.20% | +47.05% | +136.57% | 39.25B | |
| Weighted average by Cap. | +0.24% | -0.40% | +58.35% | +145.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.63M 761K 676K 631K 575K 1.08M 73.12M 1.09M 2.96M 37.38M 2.86M 2.79M 120M | 172M 17.16M 15.24M 14.23M 12.97M 24.46M 1.65B 24.68M 66.71M 843M 64.41M 63.01M 2.71B |
| Net income | -99.17M -9.88M -8.78M -8.19M -7.47M -14.09M -950M -14.22M -38.43M -486M -37.1M -36.3M -1.56B | -33.34M -3.32M -2.95M -2.76M -2.51M -4.74M -319M -4.78M -12.92M -163M -12.47M -12.2M -524M |
| Net Debt | 21.31M 2.12M 1.89M 1.76M 1.61M 3.03M 204M 3.06M 8.26M 104M 7.97M 7.8M 335M | -172M -17.14M -15.23M -14.21M -12.95M -24.43M -1.65B -24.66M -66.65M -842M -64.35M -62.95M -2.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | SEK 6.200 | -2.36% | 15,358 |
| 01/10/26 | SEK 6.350 | +0.16% | 16,136 |
| 30/09/26 | SEK 6.340 | +0.63% | 1,831 |
| 29/09/26 | SEK 6.300 | -3.08% | 18,842 |
| 28/09/26 | SEK 6.500 | -0.15% | 6,295 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMU Stock
Select your edition
All financial news and data tailored to specific country editions
